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Abstract
The most frequent trinucleotide repeat found in human disorders is the CAG sequence. Expansion of CAG repeats is mostly
found in coding regions and is thought to cause diseases through a protein mechanism. Recently, expanded CAG repeats
were shown to induce toxicity at the RNA level in Drosophila and C. elegans. These findings raise the possibility that CAG
repeats may trigger RNA-mediated pathogenesis in mammals. Here, we demonstrate that transgenic mice expressing EGFP
transcripts with long CAG repeats in the 39 untranslated region develop pathogenic features. Expression of the transgene
was directed to the muscle in order to compare the resulting phenotype to that caused by the CUG expansion, as occurs in
myotonic dystrophy. Transgenic mice expressing 200, but not those expressing 0 or 23 CAG repeats, showed alterations in
muscle morphology, histochemistry and electrophysiology, as well as abnormal behavioral phenotypes. Expression of the
expanded CAG repeats in testes resulted in reduced fertility due to defective sperm motility. The production of EGFP protein
was significantly reduced by the 200 CAG repeats, and no polyglutamine-containing product was detected, which argues
against a protein mechanism. Moreover, nuclear RNA foci were detected for the long CAG repeats. These data support the
notion that expanded CAG repeat RNA can cause deleterious effects in mammals. They also suggest the possible
involvement of an RNA mechanism in human diseases with long CAG repeats.
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Introduction
The expansion of unstable trinucleotide repeats underlies a
number of human disorders, which can be grouped into two
categories according to the location of the repeats. In the first
category, dominantly inherited neurodegenerative disorders are
triggered by the expansion of CAG repeats located in the coding
region. Examples of disorders belonging to this group include
Huntington’s disease (HD) and spinocerebellar ataxias (SCAs)
types 1, 2, 3, 6, 7, and 17. In the second category, the expansion of
different repeats, including CGG, GAA, CTG, and CAG, occur
within the non-coding or untranslated regions (UTR), leading to
fragile X syndrome (FRAX), Friedreich’s ataxia (FRDA), myotonic
dystrophy type 1 (DM1), SCA8, and SCA12 [1,2,3,4,5].
Most CAG expansions are less than 150 repeats and are located
in coding regions and translated into polyglutamine tracts within
the corresponding protein. Despite that the expansions occur over
a wide range of genetic loci, there are common features to these
disorders, suggesting that they may share a similar pathogenic
mechanism. Toxic gain of function involving formation of
polyglutamine aggregates, protein misfolding and transcriptional
dysregulation, has been shown to result in neuronal cell toxicity
[1,2,6]. In addition, loss of neurotrophic support due to reduced
protein activity caused by polyglutamine expansions may also
contribute to the pathogenesis of neurodegeneration [7].
In contrast to the repeat expansions located within coding
regions, expansions located outside of coding sequences are usually
very large and do not alter the sequences of the affected proteins.
Recent studies have revealed a role for RNA in the pathogenesis of
the dominantly inherited non-coding repeat disorders [5,8,9]. The
best-studied example of this type is DM1. DM1 is a multisystemic
disorder characterized by skeletal muscle wasting and myotonia,
cardiac conduction defects, insulin resistance and cataracts. It is
caused by an expansion of CTG repeats in the 39 UTR of the
DMPK gene [10]. Studies in animal models have shown that
haploinsufficiency of the DMPK protein contributes only partially
to the DM1 phenotype [11,12]. In contrast, mice expressing
mRNA with long CUG repeats in the 39 UTR of either DMPK or
an unrelated transgene developed the major features of DM1
[13,14,15]. These findings, together with the discovery that
expansion of CCTG repeats in a second locus (DM2, located in
intron 1 of the ZNF 9 gene) also leads to a clinical presentation that
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repeats act trans-dominantly. The transcripts of expanded CUG/
CCUG repeats form highly stable hairpin structures [17] and
accumulate as foci in the nucleus [18,19,20]. The muscleblind-like
(MBNL) proteins, which bind to double-stranded CUG/CCUG
repeats in vitro [21,22], have been shown to colocalize with these
RNA foci in DM tissues [20,22,23]. A model has been proposed in
which the sequestration of the MBNL proteins, along with the
accompanying upregulation of CUG-binding proteins [24,25],
results in disruption of alternative splicing of genes that are
misregulated in DM [26,27,28], leading to the multisystemic
clinical features [3]. Consistent with this model, both muscleblind
knockout mice and transgenic mice overexpressing CUG-BP1
displayed the pathological features and the splicing misregulation
that are associated with DM [29,30].
RNA-mediated pathogenesis is not limited to CUG repeats. For
example, the CGG repeats in the Fragile X premutation range
(60–200 repeats) cause a clinically distinct disorder called Fragile
X tremor ataxia syndrome (FXTAS) [31]. Recent studies using a
Drosophila model suggest that the CGG repeat-containing RNA is
pathogenic [32,33,34]. This observation raises an interesting
question as to whether other triplet expansions, such as CAG
repeats, can have a pathogenic role at the RNA level. Indeed, not
all disease-causing CAG repeats are in the coding region. For
example, CAG repeats in SCA12 are located in the untranslated
region. CAG repeats in the disease-related transcripts can form
stable hairpin structures similar to those detected in DM1
[17,35,36], and RNA-binding proteins that specifically interact
with CAG repeat sequences have been reported [37]. Further-
more, long CAG repeats formed RNA foci when introduced into
cultured cells, and MBNL1 colocalized with these foci [38].
However, controversial results have been reported in Drosophila
models of CAG expansions. In a study comparing the effects of
expanded coding CAG/CAA repeats and untranslated CAG
repeats, only constructs expressing polyglutamine at the protein
level were shown to cause neurodegeneration [39], thus ruling out
a role for CAG RNA as the pathogenic agent. On the other hand,
modifier screening in the Drosophila models of SCA1 and SCA3 led
to identification of genes that encode RNA-binding proteins [40]
and the muscleblind protein [41], respectively, suggesting that
alteration of RNA processing is relevant to SCA pathogenesis.
Introduction of a SCA3 transgene containing CAG/CAA-
interrupted codons (which encoded the identical amino acids)
into flies dramatically mitigated the toxicity observed in flies
expressing the pure CAG-encoded protein [41], which further
supports the notion that RNA toxicity caused by CAG repeats
participates in the neuronal degeneration in SCA3. Moreover, we
have recently demonstrated that expanded CAG repeat RNA was
toxic in C. elegans [42]. Our finding suggests that the pathogenic
effect of CAG repeat RNA could be evolutionarily conserved.
To directly test the pathogenic role of CAG repeat RNA in a
mammalian system, we generated transgenic mice expressing short
and long CAG repeats in the 39 UTR of the enhanced green fluorescent
protein (EGFP) gene. Here, we present evidence showing that
normal muscle physiology and sperm motility are impaired in the
long CAG-expressing mice. These results suggest that RNA
containing expanded CAG repeats can be deleterious to mammals
as well as invertebrates.
Results
Generation of transgenic mice
To determine if untranslated CAG repeat expansion causes
pathogenic effects, we generated transgene constructs containing
the EGFP gene with 0, 23 or 200 CAG repeats (designated as
CAG0, CAG23 and CAG200, respectively) in the 39 UTR (Fig. 1A).
Transgene expression was directed to the skeletal muscle with the
gamma-sarcoglycan (gsg) promoter [43] in order to compare the
effects of CAG repeats to those caused by CTG repeats [13,14].
Transgenic mice were initially screened by PCR and the results
were subsequently confirmed by Southern blot analyses. The
presence of CAG repeat sequences with the correct length in the
transgenic mice was also checked by PCR-based Southern blot
using a (CAG)10 oligomer as a probe (Fig. 1B). Three CAG0
(CAG0-10, -24 and -41), 7 CAG23 (CAG23-1, -11, -16, -25, -26,
-31 and -35) and 6 CAG200 (CAG200-27, -31, -32, -57, -62 and -65)
transgenic founder animals were generated and bred to establish
independent lines. The transgenic animals used for subsequent
analyses were randomly selected from the lines shown in Table S1.
Transgene expression
The expression of each transgene was first verified by RT-PCR
analysis. The EGFP transcripts were present in heart, skeletal
muscle, diaphragm, testis and ovary (Fig. 2A), consistent with the
reported tissue specificity of the gsg promoter [43]. Independent
lines of CAG0 (-10, -41), CAG23 (-16, -31, -35) and CAG200 (-32,
-57, -62) were analyzed, and all lines exhibited similar patterns of
tissue distribution. Northern blotting revealed that the length of
the EGFP transcript in the CAG200 lines was approximately
600 bp longer than that in the CAG0 lines, as expected (Fig. 2B).
In all analyzed lines, there was no noticeable difference in the
levels of transcript expression. However, the EGFP protein levels
were significantly reduced in the tissues of the analyzed CAG200
lines (Fig. 2C). This decreased protein expression was also reflected
in the low GFP fluorescence intensity observed in CAG200 muscle
sections using a fluorescence microscope (Fig. 2D). Thus, the
Figure 1. Generation of transgenic mice. (A) Diagram of the
transgene constructs. The transgenes contain the gamma-sarcoglycan
(GSG) promoter fused with the EGFP coding sequence and followed by
SV40 polyadenylation signals (poly A). Insertion of 23 or 200 CAG
repeats was made downstream of the EGFP stop codon and before the
poly A sequence. Locations of primers (f1, f2, r1 and r2) used for PCR are
marked. (B) PCR-based Southern blot analysis. Tail DNA from different
founder animals (as indicated by the numbers) generated from the
three constructs were PCR-amplified using primers f1 and r2, which
generated fragments of 632 bp, 701 bp and 1,232 bp, from CAG0,
CAG23 and CAG200 transgenes, respectively. Upper panels, ethidium
bromide-stained agarose gels; lower panels, blots of PCR products
hybridized with a CAG10 probe.
doi:10.1371/journal.pone.0016417.g001
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transcript resulted in decreased protein production.
To determine if cryptic translation leading to polyglutamine-
containing protein product occurred in the transgenic lines, we
performed western blotting using an anti-polyglutamine monoclo-
nal antibody (1C2). No suspicious proteins with polyglutamine
tracts were detected in tissue extracts from the transgenic lines
(Fig. 2E); thus, the potential for polyglutamine protein contribu-
tion to the phenotypes described below was excluded.
Histological analysis of muscle
Skeletal muscle from adult transgenic mice (Table S1) was
prepared for histological examination of the muscle morphology.
No signs of fibrosis, inflammation or regeneration in muscle fibers
from any of the mice were observed. In non-transgenic (NT),
CAG0 and CAG23 mice, the shape and size of the muscle fibers
were homogeneous, and most nuclei were peripherally situated
(Fig. 3A, C, E, G). In CAG200 mice, we observed muscle fibers of
various sizes and shapes, increased intermyofibrillar connective
tissue, split fibers and centronucleated fibers (Fig. 3B, D, F, H). In
addition, the nuclei appeared larger, and the relative nucleus-to-
fiber ratios for two CAG200 lines (1.4160.04 and 1.4260.06) were
higher than those for NT and CAG0 mice (1.0560.03 and
1.0260.03, respectively; p,0.001) (Fig. 3I).
Histochemical staining for the oxidative reaction by succinate
dehydrogenase (SDH) and for nicotinamide adenine dinucleotide
reductase (NADHR) also revealed abnormal staining patterns in
CAG200 mice. A modified SDH reaction using phenazine
methylsulfate revealed the presence of fibers with heavy staining
known as ‘‘ragged blue’’ fibers in sections from CAG200 lines
(Fig. 4D). The heavy staining reflected a marked excess of
mitochondria and was not seen in the muscle of control or CAG23
mice (Fig. 4A–C). The fibrillar network of NADHR reactivity is
shown in Fig. 4E–J. The intermyofibrillar lattice pattern and
subsarcolemmal pockets of NADHR reactivity mark the normal
distribution of mitochondria (Fig. 4E, I). Both CAG0 and CAG23
mice showed a similar pattern to that observed in NT (Fig. 4F, G).
In CAG200 mice, however, the network was irregular. Many fibers,
both type I and type II, displayed an unusual ‘‘hollow’’ lattice
pattern in which NADHR activity was lacking in one or more
areas within the fibers (Fig. 4H, J). These ‘‘moth-eaten’’ fibers were
not artifacts because they were reproducible in multiple mice from
three CAG200 lines. Finally, staining for ATPase activity revealed
that type I fibers were predominant and grouped in the soleus
muscle of CAG200 mice (Fig. 4L). In contrast, the two fiber types
appeared to be present in similar numbers and were randomly
distributed in a similar muscle area in NT, CAG0 (data not shown)
and CAG23 mice (Fig. 4K).
Phenotype analysis
Mice expressing the CAG200 construct showed normal weight
gain and did not have an overt phenotype. However, some of these
Figure 2. Transgene expression. (A) RT-PCR of RNA isolated from different adult tissues. Representative gels showing expression of EGFP in CAG0,
CAG23 and CAG200 lines. Amplification of GAPDH was used as an internal control. +, with RT; 2, without RT. S, skin; Li, liver; H, heart; L, lung; M, muscle
(soleus); T, testis; D, diaphragm; P, pancreas; O, ovary. (B) Northern blot analysis. Representative blot showing skeletal muscle RNA from non-
transgenic (NT), CAG0, CAG23 and CAG200 animals hybridized with an EGFP probe or a control GAPDH probe. Relative RNA expression levels (E/G, EGFP
divided by GAPDH) are shown below. (C) EGFP protein expression in the transgenic lines determined by western blotting using an anti-EGFP
antibody. H, heart; M, muscle; D, diaphragm. Expression of b-tubulin was used as a loading control. (D) EGFP fluorescence was observed using frozen
sections from the soleus muscle with a fluorescence microscope. Reduced fluorescence in CAG200 muscle is consistent with the reduced protein
expression shown in (C). (E) Detection of polyglutamine-containing protein with a mouse anti-polyglutamine monoclonal antibody (1C2). Protein
extracts from the muscle of three mouse lines (50 mg each) and two cell lines transfected with expanded ataxin-3 proteins (54Q, 109Q) (12.5 mg each)
were used. Arrowheads indicate the endogenous (45 Kd) and mutant ataxin-3 proteins with 54 or 109 CAG repeats. The position of the wells is
indicated to verify the absence of insoluble 1C2-positive proteins. Actin expression was used as a control.
doi:10.1371/journal.pone.0016417.g002
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convulsions. To obtain a quantifiable phenotype assessment, we
carried out a series of behavioral and functional analyses [44].
Results from two of these assays showed significant difference
between control and CAG200 mice. When assayed by a locomotor
activity test, the CAG200 mice showed reduced cage activity, as
they crossed fewer squares per minute (Fig. 5A). In a narrow bar
hang assay, these mice became fatigued and fell more quickly than
control animals, suggesting that they had a muscle weakness
phenotype (Fig. 5B).
In addition to the muscle phenotype, CAG200 mice also
displayed reduced fertility. The mean litter size in CAG200 lines
was similar to the CAG0 control mean value (7.6 pups per litter
over 20 litters versus 8.4 pups per litter over 31 litters,
respectively); however, breeding efficiency was greatly reduced in
CAG200 lines. The time between new litters in a heterozygous
CAG200-NT cross ranged from 6 to 8 weeks, compared to a range
of 3 to 4 weeks in a normal or CAG0-NT cross. It took 9 to 12
weeks for a litter to be born from a mating between two
heterozygous CAG200 mice, if any litter was born; approximately
30% of these matings resulted in no offspring at all.
Sperm function and mitochondrial activity
To understand the basis for reduced fertility in CAG200 mice,
we first examined tissue sections from the testes, epididymis and
ovaries. However, no significant differences were found in the size
or histological features of these tissues between control and
CAG200 mice (data not shown). Further analysis revealed that,
although the sperm counts per epididymis were comparable, the
motility of sperm from CAG200 males was greatly reduced to 0.3%
over a 1-hour time frame (Fig. 6A) compared to 57–59% motility
in CAG0 and NT males. When examined by electron microscopy,
approximately two-thirds of the CAG200 sperm showed structural
defects in their axonemes (Table S2), with loss of one outer doublet
from the normal 9+2 microtubule arrangement (Fig. 6B, top
panels). In addition, empty and abnormally shaped mitochondria
were observed along the midpiece (Fig. 6B, lower panels).
To evaluate mitochondrial function, spermatozoa were stained
with rhodamine123 (Rh123) and propidium iodide (PI) and
subsequently sorted by flow cytometry. Rh123 specifically
accumulates in the mitochondria and is recognized as an indicator
of mitochondrial membrane potential (MMP), which has been
shown to correlate positively with sperm motility [45,46]. As
shown in Fig. 6C, most of the sperm cells from control males had
relatively high Rh123 fluorescence, whereas most sperm cells from
CAG200 males had low Rh123 fluorescence. All of the sperma-
tozoa had low PI fluorescence, indicating that they were viable.
This analysis confirmed that sperm from CAG200 males had
defective mitochondrial activity, which led to reduced sperm
motility and fertility.
Muscle electrophysiology
Previous studies have shown that expression of untranslated
CUG expansions in the skeletal muscle can result in repetitive
electromyographic discharges [13,14,47]. To determine if there
were defects in muscle membrane conductance in CAG200 mice,
sharp microelectrode recordings were performed on excised
diaphragm muscle fibers. A single action potential was triggered
in NT or CAG200 fibers by applying a 12 nA current (Fig. 7A). No
difference in the current threshold or latency was observed,
indicating that muscle membrane conductance was not impaired
by the CAG expansion.
Because the patterns of mitochondrial enzyme activity were
altered in the muscle of CAG200 mice (Fig. 4), we next measured
Figure 3. Muscle morphology. Hematoxylin and eosin-stained
paraffin sections of soleus muscle oriented as longitudinal (A–D) or
transverse sections (E–H) from 2-month-old non-transgenic (A, E), CAG0
(C), CAG23 (G), and CAG200 (B, D, F, H) animals. Note that the fiber
diameters in CAG200 mice (B) are not as uniform as in the control (A) and
that multiple rounded nuclei are observed (D). Some nuclei are located
internally (arrowheads, F, H) instead of peripherally (C, E, G), and there
are signs of split fibers (arrows in F) and angular fibers (arrow in H). (I)
Quantification of nuclei (expressed as the nuclei-to-cell ratio). Nuclei
and cells in 10 fields in each of four sections from each transgenic line
(NT, CAG0-24, CAG23-11, CAG200-32, -62 and one homozygous mouse)
were counted using 4006 magnification; the average values are
presented. *P,0.001. (A–B), 2006; (C–D), 4006; (E–F), 2506; (G–H),
4006.
doi:10.1371/journal.pone.0016417.g003
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Fig. 7B, contracture of the isolated phrenic-nerve diaphragm was
induced significantly by 5 Hz nerve-evoked stimulation for 20 min
in CAG200 but not in NT, CAG0, or CAG23 mice (lower panels).
Table 1 summarizes the contracture force detected in the different
transgenic lines. In contrast, under metabolic stress conditions
(glucose-free Krebs solution), contracture was induced in the
diaphragms of all mice, including controls, using the same
stimulation method (Fig. 7B upper panels). This result indicates
that CAG200 mice have a muscle defect associated with energy
metabolism.
RNA foci and splicing analysis
Expression of transcripts with expanded CUG or CAG repeats
has been shown to result in nuclear accumulation of discrete RNA
foci [20,38,41,42]. Similar inclusions are also found in cells
expressing Fragile X premutation CGG repeats [32]. To
determine if expression of untranslated CAG repeats in muscle
also induce RNA foci formation, we performed fluorescence in situ
hybridization (FISH) on muscle sections from different lines of
mice (Fig. 8A) and on C2C12 myoblasts that were transfected with
untranslated CAG or CUG repeats (Fig. 8B). Punctuate nuclear
foci were detected by a labeled (CTG)13 probe in CAG200 cells,
but not by a (CAG)13 probe (data not shown). As expected, RNA
foci were also detected in CUG200-expressing cells, but not in cells
expressing the CAG0 construct. The RNA foci were also found in
myoblasts expressing 58 CAG repeats (CAG58). The proportion of
cells with RNA foci was comparable among CAG58, CAG200 and
CUG200-expressing cells, but the number of foci per nucleus was
significantly increased in CAG200/CUG200-expressing cells (Table
S3). Moreover, the foci observed in myoblast cells were colocalized
with endogenous MBNL (Fig. 8B).
Next, we examined whether expression of untranslated CAG
repeat expansions affected splicing, as has been observed with
CUG repeat RNA. We performed RT-PCR for cardiac troponin T
(cTNT), chloride channel protein 1 (ClC-1), and Mbnl1 genes using
RNA isolated from cardiac and skeletal muscles of NT, CAG0 and
CAG200 mice. There were no noticeable differences in the splicing
patterns of these endogenous genes in the transgenic lines (Fig. S1).
Thus, these results suggest that CAG repeat RNA may cause
deleterious effects through pathways that are distinct from those
utilized by CUG repeat RNA.
Figure 4. Histochemical analysis of muscle. Representative results showing frozen sections of the soleus muscle from 8-month-old non-
transgenic (A, E, I), CAG0
-24 (B, F), CAG23-11 (C, G, K) and CAG200-32 (D, H, J, L) animals. (A–D) Staining for succinate dehydrogenase (SDH). Note that
normal fibers show very little reaction, whereas ‘‘ragged blue’’ fibers (arrows) are detected in lines CAG200-32 (D) and CAG200-62 (data not shown). (E–
J) Staining for NADH-tetrazolium reductases. Note the altered fiber type grouping, moth-eaten patterns, and focal lack of intermyofibrillar network
enzyme activity (H, J, arrows) in CAG200 mice compared to clear fiber type distinctions (E–G) and uniform lattices (I) in control animals. (K, L) Staining
for ATPase activity at pH 4.3. Type I fibers are black and type II fibers are cream. Type I predominance is seen in CAG200 mice (L). A–H, 1606; I–J, 4006;
K–L, 2506.
doi:10.1371/journal.pone.0016417.g004
Figure 5. Phenotypic analysis of transgenic mice. (A) Grip
strength test. Mice were suspended by the forelimbs on a narrow bar
and the amount of time before falling was recorded. (B) Cage activity
test. CAG200 lines displayed reduced locomotion activity as measured
by a grid assay. All data represent the averages from 5 mice that were
each tested 3 times (A and B). *, P,0.001; **, P,0.01 (compared to NT,
CAG0, or CAG23; F test).
doi:10.1371/journal.pone.0016417.g005
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Previous data showing that CAG repeat RNA forms stable
hairpin structures and nuclear foci both in vitro and in vivo have
supported a role for CAG repeat RNA in pathogenesis. Recently,
CAG repeat RNA was shown to induce toxicity in Drosophila and
C. elegans [41,42]. In this study, we provide the first experimental
demonstration that non-coding CAG expansion can also be
deleterious in a mammalian system.
In the tissues of CAG200 mice, the level of translated EGFP
protein was significantly reduced, whereas the transcript level was
not affected by the repeat sequence (Fig. 2B–D). Th effect on
translation reduction has also been reported for non-coding CUG
[48,49], CGG [50] and CAG [42] repeats. One possible
explanation for this effect is that the double stranded hairpin
structures formed by these repeats [17,36] lead to a common
mechanism of translation impediment. Alternatively, the reduced
protein level may result from nuclear retention of long repeat-
containing transcripts. Accordingly, nuclear foci were observed in
the muscle cells of CAG200 mice (Fig. 8), and transcripts
containing expanded CUG, CAG and CGG repeats have all
been shown to accumulate in the nuclei [19,23,32,38,42]. We did
not detect any cryptic translation products containing expanded
polyglutamine (Fig. 2E), which argues against a protein mecha-
nism contributing to the observed phenotypes. The fact that CAG0
and CAG23 mice, which expressed high levels of EGFP protein,
lacked a discernable phenotype further supports the notion that
expanded CAG repeat RNA is deleterious.
Different lines of CAG200 mice displayed consistent myopathic
changes such as internalized nuclei, fiber splitting, increased
nucleus-to-fiber ratio and loss of fiber type distinction. These
pathological features somewhat resemble those observed in the
Figure 6. Sperm motility and mitochondrial function. (A) Counts of total sperm (gray) and motile sperm (white) after a 1-hr incubation at 37uC
(n=6 per group). The average counts are shown below the histogram. Percent sperm motility was determined by dividing the number of motile
sperm by total sperm counts. (B) Structure of the sperm tails. Electron microscopy revealed structural defects in the microtubule arrangement of
axonemes (loss of one outer doublet; upper right panel, arrows) and in the mitochondria along the midpiece (lower right panel, arrows) in some
sperm tails of CAG200 mice. (C) Flow cytometric sorting of rhodamine (Rh123)- and propidium iodide (PI)-stained sperm cells. Horizontal scale,
intensity of Rh123; vertical scale, intensity of PI. Note that most sperm cells from CAG200 males are gated with low PI and low Rh123 fluorescence,
indicating that they are viable, but have low mitochondrial activity.
doi:10.1371/journal.pone.0016417.g006
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transcripts [13,14]. Other histological features such as the ragged
blue fibers and the moth-eaten fibers, both typical of mitochon-
drial myopathies, have also been noted in muscle biopsies from
DM patients [51]. However, the key features of DM, muscle
wasting and myotonia, were not detected in CAG200 mice. In
addition to their muscle phenotype, CAG200 mice showed a
reduced breeding efficiency. Because the testis histology and sperm
counts were normal in these mice, the reduced breeding efficiency
could be attributable to the poor sperm motility and defective
axoneme structures observed in the CAG200 transgenics (Fig. 6).
Together, the features of the CAG200 phenotype are suggestive of
mitochondrial dysfunction.
There is an increasing amount of evidence that mitochondrial
dysfunction plays a role in the pathogenesis of neurodegenerative
disorders [52]. For example, defects in energy metabolism have
been demonstrated in the skeletal muscle from patients with HD
[53,54]. This observation is of particular interest because the
defect is correlated with the expansion of CAG repeats. CAG200
mice displayed lower grip strength and reduced locomotor activity,
indicating that these mice may have muscle weakness and altered
energy metabolism. Consistent with this notion, significant
contracture was measured in the diaphragm of CAG200 mice in
a condition that normally does not trigger it (Fig. 7B and Table 1).
Thus, some unknown factors associated with energy metabolism
and/or mitochondrial function may be affected by CAG repeats.
Although mitochondrial abnormalities have been previously
reported in some DM patients [51,55], it is noteworthy that
myotonic discharge induced by non-coding CUG expansion was
not detected in the CAG200 mice. Therefore, it appears that CAG
RNA expansion does not trigger the same pathogenic effects as
CUG expansion in the mammalian system (see below).
Several studies have shown that long CAG repeats form nuclear
RNA foci similar to those formed by CUG repeats [38,41,42].
While in some cases the muscleblind protein was recruited to the
foci [38,42], splicing of the reporter constructs with pre-mRNAs
that were misregulated in DM cells was not altered [38,41]. We
have consistently observed nuclear foci formation and MBNL
colocalization in muscle cells expressing 200 CAG repeats (Fig. 8).
In addition, the splicing patterns of cTNT, ClC-1 and Mbnl1 were
not altered in CAG200 mice (Fig. S1). These results suggest that the
pathways downstream of CUG and CAG repeats are separable.
However, using RNA isolated from cultured myoblasts expressing
CAG200 or CUG200 transcripts, we observed that splicing of the
ryanodine receptor 1 (Ryr1), which is altered in DM1 [56], was
shifted from an adult form to a neonatal form when the cells were
induced to differentiate (unpublished data). In worms, expression
of long CAG or long CUG repeat RNA caused a reduction in
vinculin gene expression [42]. This effect was also observed in the
muscleblind knockdown worms, suggesting that muscleblind may
participate in both CAG and CUG repeat-induced toxicity.
Interestingly, reduction of vinculin expression was also observed in
CAG200-expressing mouse myoblasts (unpublished data). Thus, it
cannot be excluded that CAG repeat RNA may act, at least in
part, through common factors that are also affected by CUG
repeat RNA.
In contrast to our study, is has also been reported that CAG
repeat RNA is not toxic [39,57,58]. It should be noted, however,
that the expanded alleles used in these studies ranged from 79 to
93 repeats, much shorter than the 200 repeats we used in this
study. It has been demonstrated that the toxicity induced by CAG
repeat RNA is dependent on length, with a size threshold of
approximately 100 repeats [41,42]. Therefore, the size of the CAG
repeat RNA is critical for its pathogenicity. The discrepancy
between study results may also be due to the presence or absence
of cell type-specific factors that are important for mediating the
observed effects. For example, CAG repeat RNA that caused
neuronal dysfunction and degeneration in Drosophila did not affect
Figure 7. Electrophysiology of the muscle. (A) Action potential. A
single action potential was triggered with a depolarizing current of
12 nA at 50-ms duration in NT and CAG200 mice. (B) Phrenic nerve-
evoked contracture of isolated diaphragm. In the presence of glucose,
significant contracture was induced by a 5-Hz stimulation for 20 min in
CAG200, but not NT, CAG0 or CAG23 mice. As a control, all mice
produced muscle contracture with a glucose-free Krebs solution using
the same stimulation method. +, with glucose; 2, without glucose.
doi:10.1371/journal.pone.0016417.g007
Table 1. Phrenic nerve-evoked muscle contracture force in
isolated mouse diaphragm.
Line Age (months) Sex Muscle contracture (g)
NT 6 F/M 0 (n=3)
CAG0-10 6 F/M 0 (n=3)
CAG23-16 2 F/M 0 (n=3)
CAG200-62 5 M 0.62
7 F 1.75
7 M 1.25
8 F 0.62
9 F 0.38
9 F 1.75
CAG200-32 6 M 1.02
10 F 0.38
10 F 0.93
NT, non-transgenic; F, female; M, male; n, number of mice analyzed.
All transgenic mice used in this assay were heterozygous.
doi:10.1371/journal.pone.0016417.t001
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repeat RNA that is directed to different tissues should clarify
whether there is a selective sensitivity to the deleterious effects of
CAG repeat RNA in distinct cell types.
HD has long been viewed as a polyglutamine disease due to a
protein toxicity. Recently, a double-stranded RNA binding protein,
PKR, was shown to be active in HD-affected tissues and to
preferentially bind to a mutant Huntingtin transcript [59,60]. Since
PKR also binds to expanded CUG repeat RNA and has been
implicated in DM pathogenesis [61], it is possible that an RNA-
mediated mechanism is also involved in HD. In this regard, it is
noteworthy that CAG200 mice displayed an energy metabolism
defect that is shared by HD. Interestingly, evidence demonstrating
the presenceof anti-senseCAGrepeat transcripts inDM1fibroblast
cells has also been reported [62]. Thus, a complex mechanism that
involves CAG repeat RNA in the pathogenesis of DM1 cannot be
excluded, and, moreover, it is supported by the observation that the
phenotypes of CAG200 mice and DM1 mice are partially
overlapping. In this study, pathologic findings in multiple transgenic
lines clearly demonstrated that transcripts with expanded CAG
repeats are deleterious in mice. Our data, together with previous
findings, suggest that an RNA mechanism may participate in
human diseases with long CAG repeats.
Materials and Methods
Transgene construction
A 1.5 kb 59-flanking sequence of mouse gamma-sarcoglycan (gsg)
gene was excised by KpnI and XmaI from plasmid pGSG-EGFP-1
(kindlyprovidedby Dr.Noguchi) [43], and inserted at the same sites
upstream of the EGFP sequence in vector pEGFP-1 (Clonetech).
This vector was used as a backbone for insertion of CAG repeat
sequence. The CAG repeat sequence was generated by polymerase
chain reaction (PCR) using two complementary primers, (CTG)10
and (CAG)17, which were denatured at 94uC for 5 min, and then
amplified by 30 cycles of 94uC, 30 sec; 37uC, 1 min; 72uC, 6 min,
and a final extension at 72uC for 10 min. The PCR products were
separated on a gel and the appropriate sized fragments were
recovered and ligated to pGEM-T Easy vector (Promega). The
number and integrity of CAG repeats in each clone was then
determined by sequencing. Two fragments containing 23 and 200
CAG repeats were cut out by EcoRI at the multiple cloning site of
pGEM-T Easy, and inserted at a modified NotI site which is
downstream of the EGFP’s stop codon and upstream of the SV40
polyadenylation sequence in the pGSG-EGFP vector. These
constructs were mapped and sequenced to confirm the correct
position, orientation, integrity and number of CAG repeats.
Production of transgenic mice
The transgene fragments containing a 1.3-kb 59-flanking
sequence of the GSG gene (Fig. 1A) were cut out from vectors
with AflII. Transgenic mice were generated by microinjecting the
purified transgene fragments into the male pronuclei of one-cell
FVB/N embryo. Mice were genotyped initially by PCR using tail
DNA with primers f2 (59-CCACATGAAGCAGCACGAC-39)
and r1 (59-GCTTTACTTGTACAGCTCGTC-39) (Fig. 1A).
PCR results were further confirmed by Southern blotting using
10 mg of tail DNA, digested with BamHI and hybridized with
either an EGFP-o rGSG promoter-specific probe. To confirm the
length of CAG repeat sequence in mice, PCR-based Southern
blotting was carried out by primers f1 (59-CTGAAGTT-
CATCTGCACCAC-39) and r2 (59-CTACAAATGTGGTATG-
GCTG-39) (Fig. 1A), using a labeled (CAG)10 probe as described
previously [63].
RT-PCR and Northern blotting
Total RNA was isolated from various tissues using the
TRIREAGENT (Molecular Research Center Inc) according to
Figure 8. Fluorescence in situ hybridization detection of nuclear foci formation. (A) Frozen muscle sections from CAG0, CAG23 and CAG200
mice were hybridized with a Cy3-(CTG)13 probe (red). The nuclei were counterstained with DAPI (blue). Merged images of red and blue signals are
shown. Nuclear foci (arrows) are only detected in CAG200 sections. (B) C2C12 cells transfected with pEGFP-CAG0/58/200 and pEGFP-CTG200 were
hybridized with Cy3-(CTG)13 and Cy3-(CAG)13 probes, respectively. Distribution of endogenous MBNL proteins was visualized by immunostaining with
an anti-MBNL antibody and a FITC-conjugated secondary antibody (green). Merged images showing superimposition of red and green signals
(yellow) demonstrate that MBNL proteins are colocalized with expanded CAG and CUG repeats. Scale bars, 10 mm.
doi:10.1371/journal.pone.0016417.g008
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transcribed with SuperScript II (Invitrogen) and one twentieth of
the cDNA was used for PCR amplification using primers f2 and
r1 as described above. Amplification of GAPDH (nt 458–774,
accession no. NM_008084) was used as an internal control. For
Northern blotting, 20 mg of total RNA from muscle was
fractionated on a 1% agarose gel containing 3.7% formaldehyde,
transferred to a nylon membrane (NEN), and hybridized with a
32P- labeled EGFP probe for 16 hr in 6XSSC, 2XDenhard’s,
0.1% SDS, and 100 mg/ml denatured salmon sperm DNA, at
60uC. The membrane was then washed and exposed to
IMAGING PLATE and read by a Phospho Image Analyzer
(Fujifilm).
Western Blot
Fresh tissues were homogenized in protein lysis buffer (15 mM
Tris, 250 mM sucrose, 1 mM EDTA and 2 mM PMSF) and
sonicated for 20 min. After centrifugation, about 100 mgo f
supernatants, as determined by the Bradford protein assay (Bio-
Rad), were fractionated by 12.5% SDS-PAGE. The proteins were
transferred to PolyScreen PVDF membranes (NEN), which were
then blocked in 3% skim milk in Tris-buffered saline (TBS). The
membranes were incubated in blocking solution with anti-EGFP
(Living Colors A.v. peptide Antibody, 1:500 dilution, BD
Biosciences Clontech), anti-polyglutamine (1C2, 1:2000 dilution,
Chemicon) or anti-tubulin b(1:1000 dilution, MD Bio) overnight,
followed by washing in TBS and incubation with HRP-conjugated
secondary antibodies (1:3000 dilution, Santa Cruz) in 3% skim
milk/TBS for 1 hr. After a final wash, bound antibodies were
visualized by SuperSignal West Pico chemiluminescent substrate
kit (Pierce). For polyglutamine-containing protein detection, two
stably transfected cell lines expressing expanded ataxin-3 proteins
with 54 and 109 CAG repeats (a gift from Dr. Hsieh M.) were used
as positive controls.
Histology and histochemistry
Muscle tissues of soleus and diaphragm were fixed in 4%
paraformaldehyde/PBS overnight at 4uC, washed in PBS,
dehydrated in increasing concentrations of ethanol and embedded
in paraffin. Sections of 5 mm were cut and stained with
hematoxylin and eosin. For histochemical reactions, fresh soleus
muscle tissues were coated with OCT and frozen at -80uC.
Cryostat sections of 8 mm were cut and immediately soaked in
incubation medium. The succinate dehydrogenase, NADH-
tetrazolium reductase and ATPase enzyme histochemistry were
carried out as described by Cash and Blumbergs [64].
Fluorescence in situ hybridization (FISH) and
immunofluorescence staining
Cryosections (10 mm) of muscle tissue from adult mice and
cultured C2C12 cells were used for FISH analysis using Cy3-
labeled (CTG)13 and (CAG)13 probes. C2C12 cells were
maintained in Dulbecco’s modified Eagle’s medium (DMEM,
Gibco), supplemented with 4 mM L-glutamine, 1% penicillin/
streptomycin, and 10% FBS at 37uCi n5 %C O 2. Cells (3610
5)
were plated into 35 mm dishes containing pre-sterilized coverslips
for 24 hours, and transfected with 2 mg of plasmids (pEGFP-
CAG0/58/200 and pEGFP-CTG200, where repeat sequences
are inserted in the 39-UTR of EGFP) using Lipofectamine
TM2000
(Invitrogen) according to the manufacturer’s instruction. FISH
analyses were carried out primarily as described [42] except that
cells were fixed in 4% paraformaldehyde (PFA) for 30 min and
were permeabilized with 0.2%Triton X-100 (in PBS/DEPC) for
5 min before post-fixation in 2% PFA. After post-hybridization
washes, cells were blocked in 16 casein solution (Vector) in
TBST (0.05 M Tris-HCl, 0.15 M NaCl, 0.1% Tween-20,
pH 7.6) for 1 hour at room temperature and then incubated
with an anti- MBNL monoclonal antibody (Santa Cruz, 1:200
dilution) at 4uC overnight. Afterwards, slides were washed three
times in TBST and incubated with a FITC-conjugated goat anti-
mouse IgG (Santa Cruz, 1:500 dilution) for 2 hours at room
temperature. After final washes in TBST, the slides were stained
with DAPI and mounted in fluorescence mounting medium
(DAKO).
Phenotype analysis
A total of 60 mice at 2, 4 and 6 months of age were analyzed.
Each 15 mice of heterozygous CAG200, CAG23, CAG0 and
nontransgenics were divided into three age-matched groups. For
grip strength test, the mice were placed with their forelimbs on a
narrow bar and the amount of time taken for the mouse to fall was
assessed. For cage activity test, mice were placed on to a grid of
squares (363 cm) in a cage, and were allowed 5 min to settle
before testing began. The mouse was observed for 3 min and the
number of squares crossed by the mouse per minute was recorded.
Both tests were repeated three times with at least 10 min between
each test.
Sperm counts, Rh123 staining, and electron microscopy
Male mice at 3 to 4 months of age were sacrificed and the cauda
epididymides were excised and placed in 4 ml of phosphate-
buffered saline (PBS). Following incubation at 37uC for 1 hour, the
spermatozoa were observed and counted by a hemacytometer
under a light microscope. Sperm from 6 males of each group was
counted and analyzed, and the numbers were averaged. For
Rh123 staining, the spermatozoa were incubated with Rh123
(5 mg/ml in PBS) at 21uC for 30 min, submitted to a centrifuga-
tion step (5006g 5 min) and then incubated with fresh PBS at
21uC for 45 min to eliminate nonspecific binding of the dye. After
recentrifugation at 5006g for 5 min, the spermatozoa were
counterstained with PI (0.05 mg/ml in PBS) for 5 min and then
subjected to flow cytometric analysis. For electron microscopy, the
spermatozoa released from epididymides were washed with PBS
for three times, pelleted by centrifugation at 10006g for 20 min,
and fixed in 4% paraformaldehyde plus 2.5% glutaraldehyde in
0.1 M cacodylate. Following post fix in 2% osmium tetroxide, the
pellets were embedded in spurr. The thin sections were examined
in a Joel 1200EX electron microscope after double staining with
uranyl acetate and lead citrate.
Muscle action potential and contracture recordings
Conventional microelectrode recording techniques were used.
The glass microelectrodes were filled with 3 M KCl and had
resistance in the range 5–15 MV. The mouse diaphragm was
placed in modified Krebs solution (130.6 mM NaCl, 4.8 mM
KCl, 1.2 mM MgSO4, 12.5 mM NaHCO3, 2.5 mM CaCl2,
10 mM glucose, pH 7.2–7.4) and gased with 95%+5% CO2.
Muscle fiber action potentials were elicited by intracellularly
injected depolarizing current (12 nA, 100 ms), the pulses being
delivered through the bridge mode of the Axoclamp-2B (Axon
Instruments). The waveforms were recorded and analysis on a
computer with P-Clamp 9.0 software (Axon Instruments). For
contracture recording, the phrenic nerve-hemidiaphragm was
isolated as previously described [65]. The diaphragm was
suspended in 10 ml Krebs solution at 37.060.5uC and constantly
gassed with 95% O2+5% CO2. Subsequently the solution was
substituted by either fresh Krebs solution or glucose-free Krebs
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of diaphragm were elicited by indirect stimulation of the phrenic
nerve with supramaximal rectangular pulses of 0.05 ms duration
at 5 Hz, and recorded with an isometric transducer (Grass FT.03)
on a Gould Model TA240 polygraph. The muscle resting tension
was adjusted to 2 g, and the preparation was then allowed to
balance for 15–20 min with 0.1 Hz before starting the 5 Hz
stimulation experiment.
Ethics Statement
This study was conducted according to the guidelines
recommended by the National Laboratory Animal Center. The
animal use protocol was approved by the Institutional Animal
Care and Use Committee of Chung-Shan Medical University
(Permit Number: 207, 315).
Supporting Information
Figure S1 RT-PCR analysis of cTNT, ClC1, and Mbnl1
alternative splicing. RNA isolated from cardiac and skeletal
muscle cells of neonatal and adult non-transgenic (NT), CAG0,
CAG200 mice was subject to RT-PCR analysis. Forward and
reverse primers used for cTNT, ClC1, and Mbnl1 were located on
exon 2/8, exon 5/8, and exon 4/6, respectively. Twenty five
cycles of PCR reactions were carried out and
32P-labeled products
were resolved on 5% polyacrylamide gels. Major splicing variants
with exon inclusion/exclusion are indicated. No difference in
splicing patterns of these genes is found among either neonatal or
adult NT, CAG0, CAG200 mice.
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